ACS Helps Plan Mammography Screening Trial

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 4 No 8
Volume 4
Issue 8

ATLANTA--The American Cancer Society's research program has awarded a $75,000 planning grant to the Union Internationale Contre le Cancer (UICC), based in Geneva, Switzerland, to study the feasibility of conducting a long-term international study on the effects of mammography in reducing breast cancer mortality in women in their 40s.

ATLANTA--The American Cancer Society's research program has awardeda $75,000 planning grant to the Union Internationale Contre leCancer (UICC), based in Geneva, Switzerland, to study the feasibilityof conducting a long-term international study on the effects ofmammography in reducing breast cancer mortality in women in their40s.

The planning grant will enable researchers to learn whether thequality of screening and levels of participation would be adequateto initiate the proposed "Eurotrial 40" population study,said Robert A. Smith, PhD, the Society's senior director of detectionand treatment.

"The planning grant is important so that the study does notsuffer from the same limitations that have plagued existing studies,such as insufficient numbers of women, less sensitive screeningprotocols, and inadequate follow-up," Dr. Smith said.

The planning phase will be directed by Dr. Marco Rosselli DelTurco, medical director of the diagnostic breast unit at the Centerfor the Study and Prevention of Breast Cancer, Florence, Italy.

If the planning process is followed by a clinical trial, the goalwould be to determine the benefits of mammography for women intheir 40s, Dr. Smith said. The proposed Eurotrial 40 would comparea group of about 85,000 women aged 40 to 42 invited to receiveperiodic screenings with a comparable group of approximately 170,000women who would not receive screening. The trial would last 10years, although researchers would follow participants until theirdeaths.

The trial would be conducted in Europe, where screening mammographyof women in their 40s is rare, rather than the United States,where mammography for this age group is more common, Dr. Smithsaid. In the United States, women might be reluctant to enrollor, if placed in the control group, might undergo screening ontheir own, he added.

Recent Videos
The use of chemotherapy trended towards improved recurrence-free intervals in older patients with high-risk tumors as determined via the MammaPrint assay.
Use of a pharmacist-directed resource appears to improve provider confidence and adverse effect monitoring for patients undergoing infusion therapy.
Reshma L. Mahtani, DO, describes how updates from the DESTINY-Breast09, ASCENT-04, and VERITAC-2 trials may shift practices in the breast cancer field.
Multidisciplinary care can help ensure that treatment planning does not deviate from established guidelines for inflammatory breast cancer management.
Photographic and written documentation can help providers recognize inflammatory breast cancer symptoms across diverse populations.
The use of guideline-concordant care in breast cancer appears to be more common in White populations than Black populations.
Strict inclusion criteria may disproportionately exclude racial minority populations from participating in breast cancer trials.
Related Content